AIM: To investigate if correction of hypovitaminosis D before initiation of Peg-interferon-alpha/ribavirin（Peg IFN/RBV） therapy could improve the efficacy of Peg IFN/RBV in previously null-responder patients with chronic genotype 1 or 4 hepatitis C virus（HCV） infection.METHODS:Genotype 1 or 4 HCV-infected patients with null response to previous Peg IFN/RBV treatment and with hypovitaminosis D（<30 ng/m L）prospectively received cholecalciferol 100000 IU per week for 4 wk[from week-4（W-4）to W0],... 

【文章來源】：World Journal of Gastroenterology. 2015,21(18)SCI

【文章頁數(shù)】：7 頁

【參考文獻】：
期刊論文
[1]Vitamin D supplementation improves sustained virologic response in chronic hepatitis C （genotype 1）-nave patients[J]. Saif Abu-Mouch,Zvi Fireman,Jacob Jarchovsky,Abdel-Rauf Zeina,Nimer Assy,Liver Unit.  World Journal of Gastroenterology. 2011(47)



本文編號：3289547